Explore
Home 
Literature 
Links 
Posts 
Molecules 
Blogs 
Zeitgeist 
Markup Help 
News 

Derek Lowes commentary on drug discovery and the pharma industry. An editorially independent blog from the publishers of Science Translational Medicine.

Most recent posts

Here’s a question that I’m not sure if there’s a general answer to: if you’re putting together a drug discovery portfolio, what percentage of the projects should be new ones, and how many should be some form of follow-up? I say that...
Robert Plenge has an excellent post here, drawing on this recent paperfrom authors at Stanford. It’s on the idea of polygenic traits and disease, a very worthwhile subject considering what’s going on in the drug industry these days.I say that because...
I’ve been meaning to link to this article by Frank David at Endpoints, on “leaner and meaner” pharma organizations. For many years now, the story has been about how drug companies are shedding staff, but David says that more recently, that...

Most popular posts

When you screen a collection of compounds against a drug target, you have to be ready to deal with the fact that some fraction – and maybe it’s a large fraction – of the hit compounds are not really hits. They’re false positives of one...
The phrase “automatic chemical design” will generally get my attention, especially when it’s applied to drug-like molecules. And that’s one the the key parts of this paper, from researchers at Harvard, Toronto, and Cambridge. From what...
Pioneering chemist John D. (Jack) Roberts of Caltech has passed away, having made it to the age of 98 (!) When I wrote The Chemistry Book a couple of years ago, I was amazed to find that he was still alive, I have to confess, but if I’d done a literature...

Latest posts linking here

Deep learning (DL) is all the rage these days and this approach to predictive modeling is being applied to a wide variety of problems, including many in computational drug discovery. As a dilettante in the area of deep learning, I’ve been following papers...
The shocks just keep on coming. Monday brought news of University of Illinois computational chemist Klaus Schulten's demise. Schulten was a student of Martin Karplus who made great strides in using molecular dynamics to simulate the behavior of not just single...
A collection of small, useful things (links):Welcome to the new blog, The Analytical Perspective, posting about success in grad school.Via Retraction Watch, we have a few: RSC AdvancesJournal of Photochemistry and Photobiology BAnd more on the Fazlul...